MicroRNA-26b-5p suppresses the proliferation of tongue squamous cell carcinoma via targeting proline rich 11 (PRR11)

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385.
   Web of Science ®Google Scholar
• Gulland A. Oral cancer rates rise by two thirds. BMJ. 2016;355:i6369.
   PubMedGoogle Scholar
• Jansen L, Buttmann-Schweiger N, Listl S, et al. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral Oncol. 2018;76:8–15.
   PubMed Web of Science ®Google Scholar
• Khosla R, Hemati H, Rastogi A, et al. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC. Liver Int. 2019;39(9):1692–1703.
   PubMed Web of Science ®Google Scholar
• Jia CM, Tian YY, Quan LN, et al. miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. Pathol Res Pract. 2018;214(9):213–221.
   Web of Science ®Google Scholar
• Wu T, Chen W, Liu S, et al. Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR-26b-5p. FEBS Lett. 2014;588(12):2107–2114.
   PubMed Web of Science ®Google Scholar
• Niu F, Kazimierska M, Nolte IM, et al. The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth. Cancers (Basel). 2020;12:6.
   Web of Science ®Google Scholar
• Zhou A, Pan H, Sun D, et al. miR-26b-5p Inhibits the Proliferation, Migration and Invasion of Human Papillary Thyroid Cancer in a beta-Catenin-Dependent Manner. Onco Targets Ther. 2020;13:1593–1603.
   PubMedGoogle Scholar
• Sun W, Qiu Z, Huang W, et al. Gene expression profiles and proteinprotein interaction networks during tongue carcinogenesis in the tumor microenvironment. Mol Med Rep. 2018;17(1):165–171.
   PubMed Web of Science ®Google Scholar
• Tian F, Zhao J, Fan X, et al. Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the cancer genome atlas database. J Thorac Dis. 2017;9(1):42–53.
   PubMed Web of Science ®Google Scholar
• Dai P, He Y, Luo G, et al. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis. J Cell Biochem. 2019;120(10):16798–16810.
   Web of Science ®Google Scholar
• Zhao Y, Huang J, Chen J. The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma. Bioengineered. 2021;12(1):3309–3321.
   PubMed Web of Science ®Google Scholar
• Ji Y, Xie M, Lan H, et al. PRR11 is a novel gene implicated in cell cycle progression and lung cancer. Int J Biochem Cell Biol. 2013;45(3):645–656.
   PubMed Web of Science ®Google Scholar
• Zhu J, Hu H, Wang J, et al. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/beta-Catenin Pathway. Cell Physiol Biochem. 2018;49(2):696–705.
   PubMedGoogle Scholar
• Chen J, Yang HM, Zhou HC, et al. PRR11 and SKA2 promote the proliferation, migration and invasion of esophageal carcinoma cells. Oncol Lett. 2020;20(1):639–646.
   PubMed Web of Science ®Google Scholar
• Lin C, Xia J, Gu Z, et al. Downregulation of USP34 inhibits the growth and migration of pancreatic cancer cells via Inhibiting the PRR11. Onco Targets Ther. 2020;13:1471–1480.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Lei Y, et al. Proline-rich 11 (PRR11) drives F-actin assembly by recruiting the actin-related protein 2/3 complex in human non-small cell lung carcinoma. J Biol Chem. 2020;295(16):5335–5349.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–7.
   PubMed Web of Science ®Google Scholar
• J A. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci. 2016;2:e67.
   Google Scholar
• Wang L, Ge S, Zhou F. MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A. Bioengineered. 2021;12(1):937–947.
   PubMed Web of Science ®Google Scholar
• Liu H, Chi Z, Jin H, et al. MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma. Bioengineered. 2021;12(1):1611–1626.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu WB, Liu KJ, et al. Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields. Cell Cycle. 2016;15(3):357–367.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Seki N, Matsushita R, et al. Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer. Br J Cancer. 2016;115(3):354–363.
   PubMed Web of Science ®Google Scholar
• Liu S, Li L, Li M, et al. Effect of miR-26b-5p on cis-diamine dichloroplatinum-induced ovarian granulosa cell injury by targeting MAP3K9. Vitro Cell Dev Biol Anim. 2020;56(3):213–221.
   PubMed Web of Science ®Google Scholar
• Li H, Xu JD, Fang XH, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323–1334.
   PubMed Web of Science ®Google Scholar
• Qi J, Luo X, Ma Z, et al. Downregulation of miR-26b-5p, miR-204-5p, and miR-497-3p expression facilitates exercise-induced physiological cardiac hypertrophy by augmenting autophagy in rats. Front Genet. 2020;11:78.
   PubMed Web of Science ®Google Scholar
• Du J, Han R, Li Y, et al. LncRNA HCG11/miR-26b-5p/QKI5 feedback loop reversed high glucose-induced proliferation and angiogenesis inhibition of HUVECs. J Cell Mol Med. 2020;24(24):14231–14246.
   PubMed Web of Science ®Google Scholar
• Song Z, Liu W, Xiao Y, et al. PRR11 Is a prognostic marker and potential oncogene in patients with gastric cancer. PLoS One. 2015;10(8):e0128943.
   PubMed Web of Science ®Google Scholar
• Sakai Y, Ohbayashi C, Yanagita E, et al. PRR11 immunoreactivity is a weak prognostic factor in non-mucinous invasive adenocarcinoma of the lung. Pathologica. 2017;109(3):133–139.
   PubMed Web of Science ®Google Scholar
• Tan S, Jiang Z, Hou A, et al. Expression of PRR11 protein and its correlation with pancreatic cancer and effect on survival. Oncol Lett. 2017;13(6):4117–4122.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang C, Mai L, et al. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer. BMB Rep. 2019;52(2):696–705.
   Web of Science ®Google Scholar
• Zhou L, Deng ZZ, Li HY, et al. Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma. Onco Targets Ther. 2019;12:2677–2693.
   PubMed Web of Science ®Google Scholar
• Lee KM, Guerrero-Zotano AL, Servetto A, et al. Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer. Nat Commun. 2020;11(1):5488.
   PubMed Web of Science ®Google Scholar
• Wang C, Yu L, Ren X, et al. The oncogenic potential of PRR11 gene in tongue squamous cell carcinoma cells. J Cancer. 2019;10(11):363–385.
   Web of Science ®Google Scholar